Esophageal stent with antireflux valve for tumors involving the cardia: work in progress
Language English Country United States Media print
Document type Journal Article
- MeSH
- Adenocarcinoma therapy MeSH
- Administration, Oral MeSH
- Surgical Mesh MeSH
- Equipment Design MeSH
- Gastroesophageal Reflux diagnostic imaging prevention & control MeSH
- Carcinoma therapy MeSH
- Cardia MeSH
- Contrast Media administration & dosage MeSH
- Middle Aged MeSH
- Humans MeSH
- Neoplasm Recurrence, Local therapy MeSH
- Stomach Neoplasms therapy MeSH
- Follow-Up Studies MeSH
- Pliability MeSH
- Polyesters MeSH
- Deglutition physiology MeSH
- Polyurethanes MeSH
- Porosity MeSH
- Deglutition Disorders therapy MeSH
- Heartburn etiology MeSH
- Radiography MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Barium Sulfate administration & dosage MeSH
- Carcinoma, Squamous Cell therapy MeSH
- Stents * MeSH
- Gastric Fundus MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Contrast Media MeSH
- Polyesters MeSH
- Polyurethanes MeSH
- Barium Sulfate MeSH
PURPOSE: To describe an esophageal stent with a polyester mesh cover and an antireflux valve, and to assess its efficacy in the treatment of patients with inoperable tumors of the gastric cardia. MATERIALS AND METHODS: Thirteen patients with adenocarcinoma of the cardia, two patients with squamous cell carcinoma, and three patients with recurrent carcinoma of the gastric fundus after surgery were treated by placement of an esophageal stent with an antireflux valve. The spiral Z stent has a porous, polyester mesh cover and an antireflux sleeve made of pliable polyurethane at its lower end. RESULTS: Placement of the stent was successful in all patients, and their dysphagia disappeared or significantly improved. All were able to swallow solid food, and no patient reported significant reflux or "gas bloat" syndrome prior to death or the end of follow-up. Two patients only complained of minor heartburn. Follow-up barium swallow studies showed the absence of significant gastroesophageal reflux in all patients. No stent migration occurred. CONCLUSION: The esophageal stent with antireflux valve has been effective in the treatment of malignant obstruction of the cardia and allowed good esophageal passage without migration and major gastroesophageal reflux.
References provided by Crossref.org